Teleflex announces results from multi-center study of UroLift
Teleflex announced the publication of positive results from a multi-center study reaffirming the safety and effectiveness of the minimally invasive UroLift System for the treatment of benign prostatic hyperplasia, or BPH, in real-world patient populations. This is the largest, most comprehensive study to examine a minimally invasive BPH procedure in a real-world setting. Results were published in the Journal of Endourology. The randomized L.I.F.T. clinical trial demonstrated that treatment with the UroLift System provides patients rapid and durable symptom relief. The minimally invasive procedure, which works without cutting, heating, or removing prostate tissue, demonstrates an excellent safety profile and preserves sexual function. Unlike BPH thermal therapies such as the most recent steam treatment, the real-world results for the UroLift System treatment showed complication rates and a patient experience that were consistent with controlled clinical trials.